A bit of an odd incident, sure, but probably a better
outcome than risking a penalty for holding someone up!
Not exact matches
These
risks and uncertainties include, among others: the unfavorable
outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways
than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those
risks and uncertainties described under the heading «
Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Such
risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the
outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time
than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific
risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
Kean added that the resistance coming from the B.C. government «leads us to the conclusion that we should protect the value that KML has, rather
than risking billions of dollars on an
outcome that is outside of our control.»
I agree Veldheer has played way better
than Watson in the past but I think his
risk of injury or just a massive decline due to age and injury history is a very likely
outcome as well.
Flint and colleagues suggested that when midwives get to know the women for whom they provide care, interventions are minimised.22 The Albany midwifery practice, with an unselected population, has a rate for normal vaginal births of 77 %, with 35 % of women having a home birth.23 A review of care for women at low
risk of complications has shown that continuity of midwifery care is generally associated with lower intervention rates
than standard maternity care.24 Variation in normal birth rates between services (62 % -80 %), however, seems to be greater
than outcome differences between «high continuity» and «traditional care» groups at the same unit.25 26 27 Use of epidural analgesia, for example, varies widely between Queen Charlotte's Hospital, London, and the North Staffordshire NHS Trust.
For healthy nulliparous women with a low
risk pregnancy, the
risk of an adverse perinatal
outcome seems to be higher for planned births at home, and the intrapartum transfer rate is high in all settings other
than an obstetric unit
The relative benefits and
risks of birth in different settings have been widely debated in recent years.1 2 3 4 5 6 7 A problem when trying to evaluate the effect of birth setting on perinatal
outcomes has been the use of actual place of birth rather
than planned place of birth to define comparison groups.
It's disturbing that high
risk moms with OBs have better
outcomes than low
risk moms with midwives.
When this 20 %
risk of death is compared to the 0.02 % rate of cord prolapse during labor at homebirth that might have a better
outcome if it happened in hospital, this means that a low
risk woman has a 1000 times higher chance of having a life threatening complication either to her life or her fetus / newborns life at planned hospital birth,
than if she plans to have an attended homebirth with a well - trained practitioner.
Women who are labelled as high -
risk and whose births are managed by OB's have better
outcomes than the low -
risk women who give birth in the midwife - led part of the delivery ward.
For low -
risk women who had never given birth before, home birth led to bad
outcomes (such as encephalopathy or stillbirth) slightly less
than 1 % of the time.
Rates of obstetrical intervention are high in U.S. hospitals, and we found large absolute differences in the
risks of these interventions between planned out - of - hospital births and in - hospital births.38 In contrast, serious adverse fetal and neonatal
outcomes are infrequent in all the birth settings we assessed, and the absolute differences in
risk that we observed between planned birth locations were correspondingly small; for example, planned out - of - hospital births were associated with an excess of less
than 1 fetal death per 1000 deliveries in multivariate and propensity - score - adjusted analyses.
An odds ratio of more
than 1 indicates that the
risk of the
outcome is increased with planned out - of - hospital birth as compared with planned hospital birth.
For all low
risk women, bootstrapped estimates showed that planned birth in settings other
than an obstetric unit was associated with cost savings and considerable stochastic uncertainty surrounding adverse perinatal
outcomes.
Nevertheless, «travel times greater
than 20 minutes [to a healthcare facility] have been associated with increased
risk of adverse neonatal
outcomes, including mortality.»
A study reported in the BMJ found that women whose pregnancies were low -
risk suffered far fewer severe negative
outcomes from home
than hospital births, especially after the first pregnancy.
So a team of Dutch researchers decided to test whether low
risk women at the onset of labour with planned home birth have a higher rate of rare but severe
outcomes (known as severe acute maternal morbidity or SAMM)
than those with planned hospital births.
Multiple trials of low
risk of bias contributed to each
outcome, and there were precise estimates with no heterogeneity greater
than 60 %.
Twelve of the included studies were judged at low
risk of bias for incomplete
outcome data on the basis that attrition rate was less
than 20 % for all
outcomes (other
than satisfaction), or missing
outcome data were balanced across groups (Begley 2011; Biro 2000; Flint 1989; Harvey 1996; Hicks 2003; Homer 2001; Kenny 1994; McLachlan 2012; North Stafford 2000; Tracy 2013; Turnbull 1996; Waldenstrom 2001).
And this inflammatory use of a «relative percentage
risk» rather
than relative
risk or absolute
risk... for example, even if assuming the writer's awkward data is valid, you can to look at infant living rates and see 99.6 % vs 98.4 %, which means there's only a 1.2 % higher
risk of bad
outcome from at - home birth
than hospital.
Homebirth is in America as Homebirth in America does, yet the Homebirth advocates who are looking at the actually data are making excuses about the worse
outcomes as they speculate that it is either due to the high
risks births that were included, or because they must have been farther away from the hospital
than just 5 minutes, or just ignoring the
outcomes data and focusing on the low intervention data.
The actual data is suggestive of a low
risk of bad
outcomes for homebirthers, but they are clearly at higher
risk than hospital birth!
Women in the planned home - birth group were significantly less likely
than those who planned a midwife - attended hospital birth to have obstetric interventions (e.g., electronic fetal monitoring, relative
risk [RR] 0.32, 95 % CI 0.29 — 0.36; assisted vaginal delivery, RR 0.41, 95 % 0.33 — 0.52) or adverse maternal
outcomes (e.g., third - or fourth - degree perineal tear, RR 0.41, 95 % CI 0.28 — 0.59; postpartum hemorrhage, RR 0.62, 95 % CI 0.49 — 0.77).
The
risk of all adverse maternal
outcomes assessed was significantly lower among the women who planned a home birth
than among those who planned a physician - attended hospital birth (Table 3).
«Pregnancy - associated melanoma is associated with higher death rates: Study sought to investigate histopathology, staging,
risk factors, and
outcomes of cutaneous melanoma in women younger
than 50.»
Commenting on the study, Dr Kuehni said: «The study stands out from many others, in that it does not content itself with showing that putative
risk factors and health
outcome are associated (which means only that they occur more often together
than would be expected by chance).
In other words, regardless of surgery timing, patients who require higher
risk procedures, such as a major liver resection due to the presence of larger or multiple metastatic tumors or high -
risk colorectal resections, have poorer
outcomes than those who underwent more minor surgery.
The five year disease - free and overall survival rates for patients with high -
risk malignant germ cell tumours remains less
than 50 %, and so accurate diagnosis and monitoring is crucial to improving
outcomes for patients.
In the article, Stamatina Iliodromiti from the University of Glasgow, UK, and colleagues found birth weight less
than 25th or greater
than 85th centile to be associated with greater
risk of adverse
outcomes compared with birth weight within these cutoffs, suggesting an expansion of the definition of «fetus at
risk» beyond the less
than 10th or greater
than 90th centile range that is commonly used to trigger surveillance of fetal well - being and / or delivery.
Taking more
than one antipsychotic can increase the
risk for complications — including drug interactions, medication side effects, and metabolic disorders — without improving
outcomes.
Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the
risk of death or stroke, a study that included more
than 24,000 patients found a lower l - year
risk of the combined
outcomes of death, heart attack or stroke without a higher
risk of bleeding, according to a study in the March 5 issue of JAMA.
She suggests that inappropriately designed fitness programs and services put users at increased
risk of injury and adverse health
outcomes rather
than providing them with the tools to build a healthy lifestyle.
A new study demonstrates that negative
outcomes have a greater influence on subsequent decisions
than positive ones do: individuals are more likely to take a big
risk following a loss
than they would after a gain.
«The results of this study were of particular interest because more
than half of the pregnant women with migraine experienced some type of adverse birth
outcome, suggesting that these pregnancies should be considered high
risk,» said study author Matthew S. Robbins, M.D., director of inpatient services at Montefiore Headache Center, chief of neurology at Jack D. Weiler Hospital of Montefiore, and associate professor of clinical neurology at Albert Einstein College of Medicine.
An analysis of clinical and institutional
risk factors that may affect survival showed that medical centers performing fewer
than five transplants per year had poorer
outcomes than high - volume centers.
Of the approximately 4,000 who were identified as at
risk for mental health problems and offered the ten - session group intervention during second grade, those who participated in a greater number of sessions showed significantly greater improvements in third - grade
outcomes than did the at -
risk students who participated in fewer sessions.
From detailed observations of the life courses of about 1000 New Zealanders, Dunedin has spun out more
than 1200 papers on questions from the
risk factors for antisocial behavior and the biological
outcomes of stress to the long - term effects of cannabis use.
Of the factors examined that combine to create the County Health Rankings, the counties ranked lowest for poverty, measured as the number of children below the poverty line, had twice the relative
risk of asthma as an
outcome from PM2.5 exposure
than those counties ranked highest (the largest difference).
While we know that other donor characteristics can influence the
risk of the patient developing Graft versus Host disease or other complications, more research is needed to determine how important different donor factors are on
outcomes other
than patient survival.»
Whatever the
outcome, these volunteers accepted personal
risk, and in most cases did so to help others rather
than themselves.
The work that garnered the honor, «An analysis of the
risk and benefit of neoadjuvant chemotherapy among patients undergoing surgery for non-small cell lung cancer,» examined data from more
than 134,000 patients in the National Cancer Database to assess the impact of neoadjuvant therapy on perioperative
outcomes, as well as long - term survival.
Rick Kittles has been researching ancestry - informative genetic markers and how they can be utilizes in genomic studies on disease
risk and
outcomes for more
than 20 years.
In another recent study published by the NEJM (3), researchers compared the health
outcomes of patients that followed the very low sodium diet recommended by the FDA and AHA, consuming less
than 3 g per day, and found that they had a higher
risk of death or cardiovascular
than those who consumed more
than 7 grams per day:
Compared with potassium excretion of less
than 1.5 grams per day, higher potassium excretion was associated with reduced
risk of the composite
outcome.
There are many studies that show that perinatal
outcomes for low
risk women in planned home birth are as good or better
than those from planned hospital births.
Bioidentical Hormone Debate Safer More Efficacious
Than Synthetic Kent Holtorf Postgraduate Medicine 2009 The Bioidentical Hormone Debate: Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious than Commonly Used Synthetic Versions in Hormone Replacement Therapy?Kent Holtorf, MD Conclusion: Physiological data and clinical outcomes demonstrate that bioidentical hormones are associated with lower risks, including the risk of breast cancer and cardiovascular disease, and are more efficacious than their synthetic and animalderived counterpa
Than Synthetic Kent Holtorf Postgraduate Medicine 2009 The Bioidentical Hormone Debate: Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious
than Commonly Used Synthetic Versions in Hormone Replacement Therapy?Kent Holtorf, MD Conclusion: Physiological data and clinical outcomes demonstrate that bioidentical hormones are associated with lower risks, including the risk of breast cancer and cardiovascular disease, and are more efficacious than their synthetic and animalderived counterpa
than Commonly Used Synthetic Versions in Hormone Replacement Therapy?Kent Holtorf, MD Conclusion: Physiological data and clinical
outcomes demonstrate that bioidentical hormones are associated with lower
risks, including the
risk of breast cancer and cardiovascular disease, and are more efficacious
than their synthetic and animalderived counterpa
than their synthetic and animalderived counterparts.
So, in other words, if Americans would just get in the recommended amounts of fruits and veggies, it would not only provide carotenoids, but more
than enough of all of them to produce the beneficial health
outcomes, including reduced
risks of cancer.
The World Health Organization recommended less
than 10 % of calories from added sugar based on its assessment of higher consumption and adverse health
outcomes.4 With the evidence of higher added sugar consumption and adverse health
outcomes accumulating, the American Heart Association recommended that total calories from added sugar should be less
than 100 calories / d for most women and less
than 150 calories / d for most men.5 Our analysis suggests that participants who consumed greater
than or equal to 10 % but less
than 25 % of calories from added sugar, the level below the Institute of Medicine recommendation and above the World Health Organization / American Heart Association recommendation, had a 30 % higher
risk of CVD mortality; for those who consumed 25 % or more of calories from added sugar, the relative
risk was nearly tripled (fully adjusted HR, 2.75).
If you are afraid to take the
risk, don't let the fear hold you back, but just prepare and accept the best of the
outcomes, rather
than the worst.